KEI’s comments to USTR on its 2024 Special 301 list
Trade
EB 154: WHO rejects Thailand’s proposal on trade and health policy coherence to support universal health coverage and health security
The 154th session of the World Health Organization’s (WHO) Executive Board will take place from 22 January 2024 to 27 January 2024 in Geneva, Switzerland. Rule 8 of the Rules of Procedure of the Executive Board of the World Health… Continue Reading
Slides of KEI side event on U.S. government use of FAR 52.227-1 for non voluntary use of patented inventions
Today KEI hosted a side event at WIPO on the United States use of FAR 52.227-1. These are the slides I used.Slide 11 provides a link to more than 350 contracts that have his clause for a variety of purposes.… Continue Reading
USITC avoids taking sides in 497 page report on WTO limited patent extension of exceptions for COVID 19
The USITC has issued a 497 page report on the WTO negotiations over TRIPS and COVID. https://www.usitc.gov/publications/332/pub5469.pdf The USITC release states: The U.S. International Trade Commission (USITC) today released a report about COVID-19 diagnostics and therapeutics and certain flexibilities under… Continue Reading
KEI response to NTIA request for comments on AI Accountability Policy, expressing concerns over trade agreement provisions which limit the transparency of source code and algorithms
KEI-NTIA-AI-Accountability-RFC KEI response to NTIA request for comments on AI Accountability Policy, expressing concerns over trade agreement provisions which limit the transparency of source code and algorithms RE: Notice by the National Telecommunications and Information Administration on 04/13/2023, Document Citation:… Continue Reading
KEI filing in ITC investigation 332–596, on COVID–19 Diagnostics and Therapeutics:, 20 March 2023
KEI comments to USTR regarding the 2023 Special 301 process
USTR-Special301-2023-KEI-coments KEI comments on the 2023 USTR Special 301 Review Comments provided by James Love, on behalf of Knowledge Ecology International 110 Maryland Avenue, NE, Washington, DC 20002 Telephone: +1.202.332.2670 James.Love@KEIOnline.Org In response to Federal Register Notice: Docket Number USTR-2022-0016… Continue Reading
KEI letter to USTR Katherine Tai regarding WTO negotiations on therapeutics and diagnostics for COVID 19
KEI Briefing Note 2022:3 Selected differences between Article 30, 31 and 44 of the WTO TRIPS Agreement as regards non-voluntary use of patented inventions
7 July 2022: Human Rights Council adopts resolution on right to health resolution with references delinkage, solidarity, global public good, and the transfer of technology and know-how
On Thursday, 7 July 2022, the 40th session of the Human Rights Council (HRC) adopted, by consensus, a resolution on Access to medicines, vaccines and other health products in the context of the right of everyone to the enjoyment of… Continue Reading